Gerstel, Ulrich
Latendorf, Ties
Bartels, Joachim
Becker, Alexander
Tholey, Andreas
Schröder, Jens-Michael
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB 877-Z2; Excellence cluster Inflammation at interfaces)
Article History
Received: 22 May 2018
Accepted: 15 October 2018
First Online: 1 November 2018
Competing Interests
: Kiel University has filed a provisional patent application with JMS as inventor. It covers cationic intrinsically disordered antimicrobial peptides (CIDAMPs) as designer peptide antibiotics, as well as the application of CIDAMPs as disinfectants and for the prevention and treatment of bacterial and fungal infections (European patent application number EP16199780.4 “Cationic intrinsically disordered antimicrobial peptides”). All other authors declare no competing interests.